Skip to main content

Detail

Sorry, this content is only available in German!
Barbara Bohle
Barbara BohleHead of the Department of Pathophysiology and Allergy Research

Center for Pathophysiology, Infectiology and Immunology (Institute of Pathophysiology and Allergy Research)
Position: Professor

ORCID: 0000-0002-5105-7985
T +43 1 40400 51140
barbara.bohle@meduniwien.ac.at

Further Information

Keywords

Allergy and Immunology

Research group(s)

  • Allergy Research
    Research Area: focuses on the elucidation of the immune mechanisms operative in the induction, maintenance and treatment of allergic disorders and the development of novel concepts for efficient and safe allergen-specific immunotherapy.
    Members:

Research interests

We are interested in elucidating the immunological mechanisms underlying the induction, maintenance and effective treatment of IgE-mediated allergy. Moreover, we characterize allergens and develop novel concepts for allergen-specific immunotherapy. 

Techniques, methods & infrastructure

Our expertise includes a broad spectrum of state-of-the-art-methodologies in cellular and molecular biology and immunology, e.g. human cell culture, magnetic cell sorting, FACS, intracellular cytokine detection, real-time PCR, live cell imaging, T cell cloning and T cell epitope mapping systems, ELISA, and immunoblotting.

We are specialized in the isolation and characterization of primary immune cells (T, B, DC, Monocytes), and allergen-specific T cell lines and clones. In addition, we perform various read-out systems for allergic responses, e.g. basophil activation assays, mediator-release experiments, facilitated allergen-binding assays, and study antigen-processing by means of antigen-uptake and degradation assays, endolysosomal proteolysis, and presentation to specific T cells.

Selected publications

  1. Kinaciyan, T. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.J Allergy Clin Immunol. 2018 Mar;141(3):1002-1008. doi: 10.1016/j.jaci.2017.07.036
  2. Polak et al. A novel role for neutrophils in IgE-mediated allergy: Evidence for antigen presentation in late-phase reactions. J Allergy Clin Immunol. 2018 Jun 18. pii: S0091-6749(18)30858-3
  3. Kitzmüller et al. Fusion proteins of flagellin and the major birch pollen allergen Bet v 1 show enhanced immunogenicity, reduced allergenicity, and intrinsic adjuvanticity. J Allergy Clin Immunol. 2018 Jan;141(1):293-299.e6.
  4. Kinaciyan, T. et al.. Recombinant Mal d 1 facilitates sublingual challenge tests of birch pollen-allergic patients with apple allergy. Allergy, p.n/a-n/a. Available at: http://dx.doi.org/10.1111/all.12781.
  5. Bohle, B. et al. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol. 2007 Sep;120(3):707-13